Review: Telaprevir, boceprevir, simeprevir, or sofosbuvir improves response in HCV type 1
Authors: Ronald L. Koretz
Journal: Annals of Internal Medicine (2014)

ACP Journal Club18 November 2014Review: Telaprevir, boceprevir, simeprevir, or sofosbuvir improves response in HCV type 1Ronald L. Koretz, MDRonald L. Koretz, MDOlive View–UCLA Medical Center, Sylmar, California, USA (R.L.K.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-161-10-201411180-02011 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationKohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312:631-40. https://pubmed.ncbi.nlm.nih.gov/25117132Clinical Impact RatingsGIM/FP/GP: Gastroenterology: Infectious Disease: References1 Wiese M, Fischer J, Lobermann M, et al; East German HCV Study Group. Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection. Hepatology. 2014;59:49-57. [PMID: 23929603] Google Scholar2 Hara K, Rivera MM, Koh C, et al. Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection? J Infect Dis. 2014;209:38-45. [PMID: 24127561] Google Scholar3 Van der meer AJ, Feld JJ, Hofer H, et al. The risk for hepatocellular carcinoma among patients with chronic HCV infection and advanced hepatic fibrosis following sustained virological response. Hepatology. 2013;58(Suppl4):280A. Google Scholar4 Koretz RL, Pleguezuelo M, Arvaniti V, et al. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database Syst Rev. 2013;1:CD003617. [PMID: 23440791] Google Scholar Author, Article, and Disclosure InformationAffiliations: Olive View–UCLA Medical Center, Sylmar, California, USA (R.L.K.)This article was published at Annals.org on 4 November 2014. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byMicro RNA ‐let‐7c suppresses hepatitis C virus replication by targeting Bach1 for induction of haem oxygenase‐1 expressionCelastrol inhibits hepatitis C virus replication by upregulating heme oxygenase-1 via the JNK MAPK/Nrf2 pathway in human hepatoma cellsEffects of microvirin monomers and oligomers on hepatitis C virusGrape Seed Extract Attenuates Hepatitis C Virus Replication and Virus-Induced InflammationN-glycosylation-mutated HCV envelope glycoprotein complex enhances antigen-presenting activity and cellular and neutralizing antibody responsesGeneration and Characterization of Monoclonal Antibodies against a Cyclic Variant of Hepatitis C Virus E2 Epitope 412-422CD36 is a co-receptor for hepatitis C virus E1 protein attachmentThe potential role of simeprevir for the treatment of hepatitis C 18 November 2014Volume 161, Issue 10Page: JC11KeywordsCohort studiesHepatitis C virusHepatocellular carcinomaInfectious diseasesInterferonsLiver diseasesPatientsSystematic reviews ePublished: 18 November 2014 Issue Published: 18 November 2014 Copyright & PermissionsCopyright © 2014 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...